Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center
ABSTRACT Importance Emicizumab (EMI) is efficacious and safe for hemophilia A (HA) prophylaxis. However, its high cost poses a challenge in China. Objective To explore the possibility of using reduced‐dosage EMI in Chinese HA children. Methods We conducted a retrospective study for HA children in ou...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wiley
2024-12-01
|
| Seria: | Pediatric Investigation |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1002/ped4.12439 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|